In addition, understanding the circadian state of the tumor itself, including whether it has a MYC-disrupted molecular circadian clock or a more intact clock as a result of MYC inhibition, will be critical to understanding when to best deliver chemotherapy to best target the tumor while limiting patient toxicity. This evidence concerns the gene CLOCK and neoplasm.